• 04.27.17

    How Will Healthcare M&A Change Under the Trump Administration?

    The healthcare M&A market continues to be among the most active sectors. In 2016, there were 939 healthcare industry deals in the U.S. with an aggregate value of approximately $71.7 billion. How will policies and goals of the new administration likely impact healthcare M&A trends? How ...

  • Heap-of-dollars-with-stethoscope

    03.08.17

    What Are the Potential Implications of Capping Federal Medicaid Funding?

    Key leaders in Congress and high-ranking members of the Trump Administration are proposing major changes to Medicaid financing through the adoption of a block grant or per capita cap. (The proposed American Health Care Act would convert Medicaid financing from the current guaranteed matching rate ...

  • Press-Interview

    03.07.17

    How Will the Trump Administration Impact Healthcare Litigation?

    Donald Trump has vowed to eliminate the Affordable Care Act (ACA), and the repeal and replace process has begun. Whatever the outcome—whether an outright repeal or a partial rollback—significant changes would be triggered in existing healthcare law. How will healthcare litigation be ...

  • Presidential-Seal-and-Podium

    01.12.17

    Election 2016: Strategic Implications for Healthcare

    Election 2016 is over, and Donald Trump is the president-elect. Republicans maintain control of the House and the Senate—and now have 33 governors and control 70 of 99 state legislative bodies. What does the Republican sweep mean for healthcare at the federal and state levels? Which ...

  • Perscription-Drug-Tablets-with-Genetic-Code-Inside

    11.16.16

    Gene Therapy: Understanding Evolving Coverage and Reimbursement Challenges

    Exciting advances in science have led to developing treatment breakthroughs—such as gene scripting therapies—that could represent the first potential cures for rare diseases and other life-threatening conditions. Gene therapies offer dramatic promise—but also come with high ...

  • Colorful-social-media-icons

    10.04.16

    Social Media for Healthcare: Optimizing Opportunities, Overcoming Legal Risks

    The rise of social media platforms has opened powerful opportunities for healthcare organizations to develop personalized strategies that engage consumers—and improve their health. The potential of these new platforms, however, can be offset by their legal risks. The emergence of ...

  • Blue-Capped-Drug-Bottles-on-Conveyor

    09.15.16

    The Election’s Impact on Pharma: Preparing for Potential Scenarios

    The 2016 election will have a major impact on both federal and state healthcare policy. To be prepared for all the possibilities, it’s critical to understand the political dynamics that will be in play under each potential scenario—and what they will mean for the life sciences ...

  • Pharmacist-Explains-Medicine-to-Customer-thumbnail

    07.27.16

    "Manatt on Medicaid" Webinar Series: Reforming Medicaid’s LTSS System

    Medicaid continues to gain scale and importance—both as the leading source of health coverage for Americans and a driver of reform in the healthcare marketplace. To give you in-depth insight into the forces reshaping Medicaid, their impact on the future and their implications for ...

  • Hospital-staff-discussing-charts

    07.20.16

    "Manatt on Medicaid" Webinar Series: The New Managed Care Rules and Their Implications

    Medicaid continues to gain scale and importance—both as the leading source of health coverage for Americans and a driver of reform in the healthcare marketplace. To give you in-depth insight into the forces reshaping Medicaid, their impact on the future and their implications for ...

  • microscopic-cell-and-needle

    06.15.16

    The Top Legal Developments for Life Sciences Companies

    Life sciences companies are facing an increasingly complex legal climate, and it is easy to miss some of the storms on the horizon. In a recent two-part webinar for Bloomberg BNA, Manatt revealed some of the most significant legal challenges that life sciences leaders need to watch in the year ...